Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.050
-0.210 (-6.44%)
Apr 29, 2026, 12:15 PM EDT - Market open
Indaptus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 8.51 | 5.79 | 13.36 | 9.63 | 39.13 | Upgrade
|
| Short-Term Investments | - | - | - | 16.81 | - | Upgrade
|
| Cash & Short-Term Investments | 8.51 | 5.79 | 13.36 | 26.43 | 39.13 | Upgrade
|
| Cash Growth | 47.02% | -56.69% | -49.45% | -32.45% | 2289.75% | Upgrade
|
| Other Receivables | - | - | - | - | 0.02 | Upgrade
|
| Receivables | - | - | - | - | 0.02 | Upgrade
|
| Prepaid Expenses | 0.41 | 0.68 | 0.62 | 0.73 | 0.96 | Upgrade
|
| Other Current Assets | 0.39 | 0.15 | 0.02 | 0.08 | 0.28 | Upgrade
|
| Total Current Assets | 9.31 | 6.62 | 14 | 27.24 | 40.39 | Upgrade
|
| Property, Plant & Equipment | - | 0.08 | 0.17 | 0.08 | 0.17 | Upgrade
|
| Other Long-Term Assets | - | 0.64 | 0.75 | 0.74 | 0.02 | Upgrade
|
| Total Assets | 9.31 | 7.34 | 14.92 | 28.06 | 40.58 | Upgrade
|
| Accounts Payable | 0.54 | 0.87 | 0.81 | 1.38 | 2.54 | Upgrade
|
| Accrued Expenses | 5.61 | 2.44 | 1.87 | 1.97 | 1.97 | Upgrade
|
| Current Portion of Leases | - | 0.08 | 0.1 | 0.08 | 0.1 | Upgrade
|
| Total Current Liabilities | 6.16 | 3.39 | 2.77 | 3.43 | 4.6 | Upgrade
|
| Long-Term Leases | - | - | 0.07 | - | 0.07 | Upgrade
|
| Total Liabilities | 6.16 | 3.39 | 2.85 | 3.43 | 4.68 | Upgrade
|
| Common Stock | 0.02 | 0 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Additional Paid-In Capital | 84.41 | 64.38 | 57.41 | 54.44 | 51.49 | Upgrade
|
| Retained Earnings | -81.29 | -60.44 | -45.42 | -29.99 | -15.67 | Upgrade
|
| Comprehensive Income & Other | - | - | - | 0.1 | - | Upgrade
|
| Total Common Equity | 3.14 | 3.94 | 12.08 | 24.63 | 35.9 | Upgrade
|
| Shareholders' Equity | 3.15 | 3.94 | 12.08 | 24.63 | 35.9 | Upgrade
|
| Total Liabilities & Equity | 9.31 | 7.34 | 14.92 | 28.06 | 40.58 | Upgrade
|
| Total Debt | - | 0.08 | 0.18 | 0.08 | 0.17 | Upgrade
|
| Net Cash (Debt) | 8.51 | 5.7 | 13.19 | 26.35 | 38.96 | Upgrade
|
| Net Cash Growth | 49.19% | -56.76% | -49.96% | -32.37% | 2279.41% | Upgrade
|
| Net Cash Per Share | 8.81 | 17.07 | 43.95 | 89.31 | 266.70 | Upgrade
|
| Filing Date Shares Outstanding | 2.24 | 0.52 | 0.3 | 0.3 | 0.29 | Upgrade
|
| Total Common Shares Outstanding | 2.17 | 0.43 | 0.3 | 0.3 | 0.29 | Upgrade
|
| Working Capital | 3.15 | 3.22 | 11.22 | 23.81 | 35.78 | Upgrade
|
| Book Value Per Share | 1.45 | 9.19 | 40.25 | 82.09 | 121.71 | Upgrade
|
| Tangible Book Value | 3.14 | 3.94 | 12.08 | 24.63 | 35.9 | Upgrade
|
| Tangible Book Value Per Share | 1.45 | 9.19 | 40.25 | 82.09 | 121.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.